Noida, UP -- (SBWire) -- 05/06/2011 -- According to our new report entitled “Clinical Trials Market in Russia”, Russian clinical trials market has been growing at a fast pace for the past few years, with 577 new trials registered in the year 2009. Russia is now being quoted as one of the attractive destinations for conducting clinical trials, as it has several special attributes that provide it a competitive edge over other European countries. Factors, such as high patient recruitment rate, huge investments, and active government participation are stimulating the market growth. Backed by all these factors, the total number of clinical trials is likely to reach the mark of 644 in 2012.
Our report has found that, the regulatory structure with regards to clinical trials in Russia impacts the market in a huge way. The authorities have been trying hard to enact measures that may result in fast approval of trial registration and approval. The developments will further ensure a speedy regulatory process for the market players, and they will be able to proceed with the study in a more structured way.
The report “Clinical Trials Market in Russia” provides a comprehensive insight into the Russian clinical trials market and its important aspects. The report also illustrates current market trends and analyzes their impact on the future sector performance. Moreover, the report provides reliable statistics on the patient profile, recruitment rate, healthcare workforce, and others to describe the availability and efficacy of growth factors.
The report provides an in-depth analysis of the overall Russian clinical trial industry potential, and illustrates about the key clinical research companies and sponsors active in the market. The report will help our clients in understanding the overall market dynamics. The report is likely to work as an investment guide for those clients, who are looking forward to invest in the Russian clinical trial industry or conduct their clinical trials in Russia.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM189.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.
Regulatory Landscape to Strengthen Russian Clinical Trials Market
Backed by factors, such as high patient recruitment rate and the government support, the number of clinical trials in Russia will reach the mark of 644 in 2012, says RNCOS.